Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2011, Article ID 853931, 11 pages
http://dx.doi.org/10.1155/2011/853931
Research Article

Safety and Pharmacokinetics of Motesanib in Combination with Panitumumab and Gemcitabine-Cisplatin in Patients with Advanced Cancer

1Sarah Cannon Research Institute, Nashville, TN 37203, USA
2Cancer Center of the Carolinas, Greenville, SC 29605, USA
3The Ohio State University, Columbus, OH 43210, USA
4Robert Wood Johnson University Hospital, UMDNJ, New Brunswick, NJ 08903, USA
5Amgen Inc., Thousand Oaks, CA 91320, USA
6Amgen Inc., South San Francisco, CA 94080, USA
7The West Clinic, Memphis, TN 38120, USA

Received 29 July 2010; Accepted 12 February 2011

Academic Editor: David Ball

Copyright © 2011 Howard Burris et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Howard Burris, Joe Stephenson, Gregory A. Otterson, et al., “Safety and Pharmacokinetics of Motesanib in Combination with Panitumumab and Gemcitabine-Cisplatin in Patients with Advanced Cancer,” Journal of Oncology, vol. 2011, Article ID 853931, 11 pages, 2011. https://doi.org/10.1155/2011/853931.